Knowledge

Ribose-5-phosphate isomerase deficiency

Source đź“ť

276:
abnormality. A third case was reported in 2018 by Sklower Brooks and colleagues, a child with neonatal onset leukoencephalopathy and psychomotor delays. A fourth case was reported in 2019 by Kaur and colleagues with progressive leukoencephalopathy and elevated urine polyols arabitol and ribitol.
228:
The first patient was a male born in 1984 to healthy, unrelated parents. Early in life, the patient had psychomotor retardation and developed epilepsy at age 4. From age 7, a slow neurological regression occurred with prominent
549:
Wang, Ching-Tzu; Chen, Yi-Chun; Wang, Yi-Yun; Huang, Ming-Hao; Yen, Tzu-Li; Li, Hsun; Liang, Cyong-Jhih; Sang, Tzu-Kang; Ciou, Shih-Ci; Yuh, Chiou-Hwa; Wang, Chao-Yung; Brummel, Theodore J.; Wang, Horng-Dar (February 2012).
751:
van der Knaap MS, Wevers RA, Struys EA, Verhoeven NM, Pouwels PJ, Engelke UF, Feikema W, Valk J, Jakobs C (December 1999). "Leukoencephalopathy associated with a disturbance in the metabolism of polyols".
256:
In 1999 van der Knaap and colleagues reviewed this case of the then 14-year-old boy and characterised the associated symptoms of RPI deficiency as the following: developmental delay, insidious
795:
Naik N, Shah A, Wamelink MC, van der Knaap MS, Hingwala D (September 2017). "Rare case of ribose 5 phosphate isomerase deficiency with slowly progressive leukoencephalopathy".
552:"Reduced neuronal expression of ribose-5-phosphate isomerase enhances tolerance to oxidative stress, extends lifespan, and attenuates polyglutamine toxicity in Drosophila" 208:
RPI can be diagnosed by gene sequencing or increased polyol levels in blood or urine. Patients also present highly elevated polyols in the brain, which can be revealed by
504:"Polyols accumulated in ribose-5-phosphate isomerase deficiency increase mitochondrial superoxide production and improve antioxidant defenses in rats' prefrontal cortex" 230: 63: 696:"Ribose-5-phosphate isomerase deficiency: new inborn error in the pentose phosphate pathway associated with a slowly progressive leukoencephalopathy" 644:"Ribose-5-phosphate isomerase deficiency: New inborn error in the pentose phosphate pathway associated with a slowly progressive leukoencephalopathy" 408:"Ribose-5-phosphate isomerase deficiency: new inborn error in the pentose phosphate pathway associated with a slowly progressive leukoencephalopathy" 838:
Brooks SS, Anderson S, Bhise V, Botti C (October 2018). "Further Delineation of Ribose-5-phosphate Isomerase Deficiency: Report of a Third Case".
245:
dysfunction of internal organs. MRI scans at age 11 and 14 revealed extensive abnormalities of the cerebral white matter and elevated levels of
161:. Artificial downregulation of RPI has been therefore suggested as a treatment against disease caused by polyglutamine neutroxicity (such as 153:
Paradoxically, downregulation of ribose-5-phosphate isomerase in Drosophila melanogaster leads to a fitter phenotype: enhanced tolerance to
694:
Huck, Jojanneke H. J.; Verhoeven, Nanda M.; Struys, Eduard A.; Salomons, Gajja S.; Jakobs, Cornelis; van der Knaap, Marjo S. (April 2004).
90:
in which it is expressed. Therefore, some of the patient's cells have a considerable amount of RPI activity, whereas others do not.
209: 125:
model and concluded that the accumulation of polyols has likely only a secondary effect on brain dysfunction, if any at all.
765: 324:"The difference between rare and exceptionally rare: molecular characterization of ribose 5-phosphate isomerase deficiency" 150:
content in the rat prefrontal cortex. Additionally, neither polyol influenced the oxidation levels of proteins or lipids.
955: 379: 146:
was increased under the influence of ribitol, while arabitol showed no such effect. Neither polyol had any impact on the
881:
Kaur, Parneet; Wamelink, Mirjam M.C.; Van Der Knaap, Marjo S.; Girisha, Katta Mohan; Shukla, Anju (2019-08-01).
323: 139:
production was elevated with the addition of ribitol, but not with arabitol. Furthermore, the activity of three
619:"Ribose 5-Phosphate Isomerase Deficiency disease: Malacards - Research Articles, Drugs, Genes, Clinical Trials" 328: 995: 322:
Wamelink, M. M.; GrĂĽning, N. M.; Jansen, E. E.; Bluemlein, K.; Lehrach, H.; Jakobs, C.; Ralser, M. (2010).
268:
and abnormal polyol metabolism. Later, Naik and colleagues reported a second case, an 18-year-old man with
47: 882: 82:, while the other encodes for a partially active enzyme. Furthermore, the partially functional allele has 642:
Huck, J. H.; Verhoeven, N. M.; Struys, E. A.; Salomons, G. S.; Jakobs, C.; Van Der Knaap, M. S. (2004).
618: 202: 74:
In the search for an explanation for this rarity, it has been found that the patient has a seldom-seen
503: 55: 966: 194: 162: 456: 1017: 883:"Confirmation of a Rare Genetic Leukoencephalopathy due to a Novel Bi-allelic Variant in RPIA" 8: 265: 198: 606: 406:
Huck JH, Verhoeven NM, Struys EA, Salomons GS, Jakobs C, van der Knaap MS (April 2004).
220:
There is no current treatment or prognosis for ribose-5-phosphate isomerase deficiency.
918: 863: 820: 777: 728: 695: 668: 643: 584: 551: 455:
Klusmann, A.; Fleischer, W.; Waldhaus, A.; Siebler, M.; Mayatepek, E. (December 2005).
432: 407: 360: 94: 922: 910: 902: 855: 812: 769: 733: 715: 673: 589: 571: 567: 531: 523: 484: 476: 437: 352: 182: 129: 93:
The molecular cause of the pathology is not fully understood. One hypothesis is that
867: 781: 364: 894: 847: 824: 804: 761: 723: 707: 663: 655: 579: 563: 519: 515: 468: 427: 419: 344: 336: 154: 58:. With four diagnosed patients over a 27-year period, RPI deficiency is the second 971: 808: 83: 66:
being the rarest, affecting two known individuals, Catherine and Kirstie Fields.
502:
Stone, V.; Kudo, K.Y.; August, P.M.; Marcelino, T.B.; Matté, C. (October 2014).
898: 472: 340: 1011: 906: 851: 719: 575: 527: 480: 234: 174: 133: 98: 914: 859: 816: 773: 737: 677: 593: 535: 488: 441: 356: 273: 242: 59: 257: 147: 140: 79: 947: 238: 190: 136: 348: 178: 122: 87: 380:"These twins are 'trapped' in their living room as work plans stall" 990: 766:
10.1002/1531-8249(199912)46:6<925::aid-ana18>3.0.co;2-j
711: 659: 457:"Influence of D -arabitol and ribitol on neuronal network activity" 423: 261: 186: 114: 750: 295:"OMIM Entry - # 608611 - Ribose 5-Phosphate Isomerase Deficiency" 269: 117:
may be toxic. However, Klussman et al. evaluated the toxicity of
106: 75: 960: 880: 454: 16:
Rare metabolic genetic disorder resulting in leukoencephalopathy
294: 158: 143: 118: 51: 321: 794: 693: 641: 405: 837: 501: 607:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3257417/
937: 508:
International Journal of Developmental Neuroscience
101:. Another possibility is that the accumulation of 46:) is a rare human disorder caused by mutations in 548: 1009: 689: 687: 401: 399: 831: 788: 744: 684: 396: 78:combination. One allele is a nonfunctional 317: 315: 727: 667: 583: 431: 165:) but also to counteract normal ageing. 377: 312: 40:Ribose-5-phosphate isomerase deficiency 25:Ribose-5-phosphate isomerase deficiency 1010: 461:Journal of Inherited Metabolic Disease 210:proton magnetic resonance spectroscopy 272:, psychomotor regression and diffuse 887:European Journal of Medical Genetics 13: 700:American Journal of Human Genetics 648:American Journal of Human Genetics 412:American Journal of Human Genetics 14: 1029: 933: 568:10.1111/j.1474-9726.2011.00762.x 874: 635: 611: 600: 542: 520:10.1016/j.ijdevneu.2014.06.009 495: 448: 378:Dalling, Robert (2017-02-10). 371: 287: 1: 280: 809:10.1212/WNL.0000000000004361 215: 168: 86:deficits that depend on the 69: 48:ribose-5-phosphate isomerase 7: 10: 1034: 899:10.1016/j.ejmg.2019.103708 840:Journal of Child Neurology 237:, and a mild sensorimotor 223: 203:global developmental delay 981: 941: 473:10.1007/s10545-005-0073-2 341:10.1007/s00109-010-0634-1 56:pentose phosphate pathway 29: 24: 852:10.1177/0883073818789316 97:may be insufficient for 195:psychomotor retardation 62:known as of now, with 163:Huntington's disease 754:Annals of Neurology 266:leukoencephalopathy 233:, some spasticity, 199:leukoencephalopathy 982:External resources 95:ribose-5-phosphate 1005: 1004: 803:(11): 1195–1196. 623:www.malacards.org 252: 248: 241:with no observed 231:cerebellar ataxis 183:cerebellar ataxia 173:Symptoms include 159:extended lifespan 130:prefrontal cortex 112: 104: 37: 36: 19:Medical condition 1025: 939: 938: 927: 926: 878: 872: 871: 835: 829: 828: 792: 786: 785: 748: 742: 741: 731: 691: 682: 681: 671: 639: 633: 632: 630: 629: 615: 609: 604: 598: 597: 587: 546: 540: 539: 499: 493: 492: 467:(6): 1181–1183. 452: 446: 445: 435: 403: 394: 393: 391: 390: 375: 369: 368: 319: 310: 309: 307: 305: 291: 250: 246: 155:oxidative stress 110: 102: 64:Fields condition 22: 21: 1033: 1032: 1028: 1027: 1026: 1024: 1023: 1022: 1008: 1007: 1006: 1001: 1000: 977: 976: 950: 936: 931: 930: 879: 875: 846:(12): 784–787. 836: 832: 793: 789: 749: 745: 692: 685: 640: 636: 627: 625: 617: 616: 612: 605: 601: 547: 543: 500: 496: 453: 449: 404: 397: 388: 386: 376: 372: 320: 313: 303: 301: 293: 292: 288: 283: 226: 218: 171: 72: 20: 17: 12: 11: 5: 1031: 1021: 1020: 1003: 1002: 999: 998: 986: 985: 983: 979: 978: 975: 974: 963: 951: 946: 945: 943: 942:Classification 935: 934:External links 932: 929: 928: 873: 830: 787: 743: 712:10.1086/383204 706:(4): 745–751. 683: 660:10.1086/383204 654:(4): 745–751. 634: 610: 599: 541: 494: 447: 424:10.1086/383204 395: 370: 311: 285: 284: 282: 279: 225: 222: 217: 214: 170: 167: 71: 68: 60:rarest disease 35: 34: 33:RPI deficiency 31: 27: 26: 18: 15: 9: 6: 4: 3: 2: 1030: 1019: 1018:Rare diseases 1016: 1015: 1013: 997: 993: 992: 988: 987: 984: 980: 973: 969: 968: 964: 962: 958: 957: 953: 952: 949: 944: 940: 924: 920: 916: 912: 908: 904: 900: 896: 893:(8): 103708. 892: 888: 884: 877: 869: 865: 861: 857: 853: 849: 845: 841: 834: 826: 822: 818: 814: 810: 806: 802: 798: 791: 783: 779: 775: 771: 767: 763: 759: 755: 747: 739: 735: 730: 725: 721: 717: 713: 709: 705: 701: 697: 690: 688: 679: 675: 670: 665: 661: 657: 653: 649: 645: 638: 624: 620: 614: 608: 603: 595: 591: 586: 581: 577: 573: 569: 565: 562:(1): 93–103. 561: 557: 553: 545: 537: 533: 529: 525: 521: 517: 513: 509: 505: 498: 490: 486: 482: 478: 474: 470: 466: 462: 458: 451: 443: 439: 434: 429: 425: 421: 418:(4): 745–51. 417: 413: 409: 402: 400: 385: 381: 374: 366: 362: 358: 354: 350: 346: 342: 338: 335:(9): 931–39. 334: 331: 330: 325: 318: 316: 300: 296: 290: 286: 278: 275: 271: 267: 263: 259: 254: 249:-ribitol and 244: 240: 236: 235:optic atrophy 232: 221: 213: 211: 206: 204: 200: 196: 192: 188: 184: 180: 176: 175:optic atrophy 166: 164: 160: 156: 151: 149: 145: 142: 138: 135: 134:mitochondrial 131: 126: 124: 120: 116: 108: 100: 99:RNA synthesis 96: 91: 89: 85: 81: 77: 67: 65: 61: 57: 53: 49: 45: 41: 32: 28: 23: 989: 965: 954: 890: 886: 876: 843: 839: 833: 800: 796: 790: 760:(6): 925–8. 757: 753: 746: 703: 699: 651: 647: 637: 626:. Retrieved 622: 613: 602: 559: 555: 544: 514:(1): 21–25. 511: 507: 497: 464: 460: 450: 415: 411: 387:. Retrieved 383: 373: 332: 329:J. Mol. Med. 327: 302:. Retrieved 298: 289: 274:white matter 260:regression, 255: 243:organomegaly 227: 219: 207: 172: 152: 127: 92: 73: 43: 39: 38: 384:WalesOnline 258:psychomotor 253:-arabitol. 148:glutathione 141:antioxidant 80:null allele 30:Other names 628:2018-03-05 556:Aging Cell 389:2021-07-31 349:1871/34686 281:References 239:neuropathy 191:spasticity 137:superoxide 84:expression 923:195760193 907:1769-7212 797:Neurology 720:0002-9297 576:1474-9718 528:0736-5748 481:0141-8955 216:Treatment 179:nystagmus 169:Diagnosis 123:neurochip 121:on a rat 88:cell type 70:Mechanism 1012:Category 991:Orphanet 915:31247379 868:51936427 860:30088433 817:28801340 782:43743595 774:10589548 738:14988808 678:14988808 594:22040003 536:24970317 489:16435225 442:14988808 365:10870492 357:20499043 304:16 March 299:omim.org 270:seizures 262:epilepsy 187:seizures 115:arabitol 972:C563212 825:9554949 729:1181951 669:1181951 585:3257417 433:1181951 224:History 144:enzymes 128:In rat 119:polyols 107:ribitol 76:allelic 54:of the 996:440706 961:608611 921:  913:  905:  866:  858:  823:  815:  780:  772:  736:  726:  718:  676:  666:  592:  582:  574:  534:  526:  487:  479:  440:  430:  363:  355:  52:enzyme 919:S2CID 864:S2CID 821:S2CID 778:S2CID 361:S2CID 50:, an 967:MeSH 956:OMIM 911:PMID 903:ISSN 856:PMID 813:PMID 770:PMID 734:PMID 716:ISSN 674:PMID 590:PMID 572:ISSN 532:PMID 524:ISSN 485:PMID 477:ISSN 438:PMID 353:PMID 306:2019 201:and 157:and 109:and 44:RPID 895:doi 848:doi 805:doi 762:doi 724:PMC 708:doi 664:PMC 656:doi 580:PMC 564:doi 516:doi 469:doi 428:PMC 420:doi 345:hdl 337:doi 1014:: 994:: 970:: 959:: 917:. 909:. 901:. 891:62 889:. 885:. 862:. 854:. 844:33 842:. 819:. 811:. 801:89 799:. 776:. 768:. 758:46 756:. 732:. 722:. 714:. 704:74 702:. 698:. 686:^ 672:. 662:. 652:74 650:. 646:. 621:. 588:. 578:. 570:. 560:11 558:. 554:. 530:. 522:. 512:37 510:. 506:. 483:. 475:. 465:28 463:. 459:. 436:. 426:. 416:74 414:. 410:. 398:^ 382:. 359:. 351:. 343:. 333:88 326:. 314:^ 297:. 264:, 212:. 205:. 197:, 193:, 189:, 185:, 181:, 177:, 132:, 948:D 925:. 897:: 870:. 850:: 827:. 807:: 784:. 764:: 740:. 710:: 680:. 658:: 631:. 596:. 566:: 538:. 518:: 491:. 471:: 444:. 422:: 392:. 367:. 347:: 339:: 308:. 251:D 247:D 113:- 111:D 105:- 103:D 42:(

Index

ribose-5-phosphate isomerase
enzyme
pentose phosphate pathway
rarest disease
Fields condition
allelic
null allele
expression
cell type
ribose-5-phosphate
RNA synthesis
ribitol
arabitol
polyols
neurochip
prefrontal cortex
mitochondrial
superoxide
antioxidant
enzymes
glutathione
oxidative stress
extended lifespan
Huntington's disease
optic atrophy
nystagmus
cerebellar ataxia
seizures
spasticity
psychomotor retardation

Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.

↑